[
    [
        {
            "time": "",
            "original_text": "贝达药业详解一季度业绩大增 受益创新药研发优势",
            "features": {
                "keywords": [
                    "贝达药业",
                    "一季度",
                    "业绩大增",
                    "创新药",
                    "研发优势"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业详解一季度业绩大增 受益创新药研发优势",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "贝达药业(300558.SZ)：已向CDE递交盐酸恩沙替尼原料药和制剂药学研究补充资料",
            "features": {
                "keywords": [
                    "贝达药业",
                    "CDE",
                    "盐酸恩沙替尼",
                    "原料药",
                    "制剂药",
                    "药学研究",
                    "补充资料"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "贝达药业(300558.SZ)：已向CDE递交盐酸恩沙替尼原料药和制剂药学研究补充资料",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]